Biogen
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis.
BIIB Key Statistics
Stock Snapshot
As of today, Biogen(BIIB) shares are valued at $201.96. The company's market cap stands at 29.83B, with a P/E ratio of 21.42.
Biogen(BIIB) stock opened on 2026-06-26 at $201.21. The price climbed to — and dipped to —.
The Biogen(BIIB)'s current trading volume is 0, compared to an average daily volume of 1.19M.
During the past year, Biogen(BIIB) stock moved between $121.05 at its lowest and $206.67 at its peak.
During the past year, Biogen(BIIB) stock moved between $121.05 at its lowest and $206.67 at its peak.
BIIB News
...
Analyst ratings
58%
of 38 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.